Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study

Long, GV (author)

Flaherty, KT (author)

Stroyakovskiy, D (author)

show more...

Gogas, H (author)

Levchenko, E (author)

de Braud, F (author)

Larkin, J (author)

Garbe, C (author)

Jouary, T (author)

Hauschild, A (author)

Chiarion-Sileni, V (author)

Lebbe, C (author)

Mandalá, M (author)

Millward, M (author)

Arance, A (author)

Bondarenko, I (author)

Haanen, JBAG (author)

Hansson, J (author)

Karolinska Institutet

Utikal, J (author)

Ferraresi, V (author)

Mohr, P (author)

Probachai, V (author)

Schadendorf, D (author)

Nathan, P (author)

Robert, C (author)

Ribas, A (author)

Davies, MA (author)

Lane, SR (author)

Legos, JJ (author)

Mookerjee, B (author)

Grob, JJ (author)

show less...

 (creator_code:org_t)

Elsevier BV, 2019

2019

English.

In: Annals of oncology : official journal of the European Society for Medical Oncology. - : Elsevier BV. - 1569-8041. ; 30:11, s. 1848-

Related links:

https://doi.org/10.1...

show more...

http://kipublication...

https://doi.org/10.1...

http://kipublication...

show less...

• Journal article (peer-reviewed)